Xilio Therapeutics had a revenue of 19.07M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 31.80M, Decreased 112.01%. In the fiscal year ending Dec 31, 2024, Xilio Therapeutics had annual revenue of 6.34M with Infinity% growth.